D. E. Shaw & Co., Inc. Intellia Therapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $333,268 - $462,384	16,900 Added 56.33%	46,900 $963,000
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $600,600 - $816,600	30,000 New	30,000 $671,000
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $913,200 - $2.43 Million	15,000 New	15,000 $2.43 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $916M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.